VLA viralytics limited
Add to My Watchlist 0.00% ! $1.75

The STORM/KEYNOTE-200 part B study (IV Cavatak & Keytruda combo...

  1. DavieJones
    255 Posts.
    lightbulb Created with Sketch. 35
    clock Created with Sketch.
    10/05/17
    10:24
    Post #: 24589428
    The STORM/KEYNOTE-200 part B study (IV Cavatak & Keytruda combo in NSCLC & metastatic bladder cancer) has added some more trial sites including 2 in Australia (Melbourne & Gold Coast).
    It looks like this trial is accelerating finally .....   Looking forward to the results.

    https://clinicaltrials.gov/show/NCT02043665

    ..
    VLA Price at posting: $1.06 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Access the Latest ASX news daily on HotCopper
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & Investment Opportunities in Australia & North America
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.